|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C12N 5/10 | (2006.01) |
| C12N 1/19 | (2006.01) | ||
| C12N 1/21 | (2006.01) | ||
| C07K 19/00 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K 14/715 | (2006.01) | ||
| C12P 21/02 | (2006.01) |
| (11) | Number of the document | 2374872 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10011212.7 |
| Date of filing the European patent application | 1999-12-16 | |
| (97) | Date of publication of the European application | 2011-10-12 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-25 |
| (46) | Date of publication of the claims translation | 2015-12-28 |
| (30) | Number | Date | Country code |
| 112752 P | 1998-12-17 | US |
| (72) |
Browning, Jeffrey, US
Miatkowski, Konrad, US
Meier, Werner, US
|
| (73) |
Biogen MA Inc.,
250 Binney Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Aktyvių TNF receptorių šeimos narių-lg sulietų baltymų aukšto lygio ekspresijos būdas ir jų gryninimas |
| A method for the high level expression of active TNF receptor family member-Ig fusion proteins and their purification |
| Payment date | Validity (years) | Amount | |
| 2018-11-21 | 20 | 347.00 EUR |